SEARCH

SEARCH BY CITATION

References

  • 1
    American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998; 21: 15511559.
  • 2
    Department of Health. National Service Framework for diabetes: Standard. London: HMS, 2001.
  • 3
    Donnelly R. Managing cardiovascular risk in patients with diabetes. Br J Diabetes Vasc Dis 2005; 5: 325329.
  • 4
    Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434444.
  • 5
    Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229234.
  • 6
    United Kingdom Prospective Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998; 317: 703713.
  • 7
    Feher ME, Elkeles RS. Lipid modification and coronary heart disease in type 2 diabetes: different from the general population? Heart 1999; 81: 1011.
  • 8
    European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diab Med 1999; 16: 716730.
  • 9
    Joint British Recommendations on prevention of coronary heart disease in clinical practice. Heart 1998, 80(Suppl 2): S1S29.
  • 10
    Ramsay LE, Williams B, Johnston GD, et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypert 1999; 13: 569592.
  • 11
    Curzio JL, Rubin PC, Kennedy SS, et al. A comparison of the management of hypertensive patients by nurse practitioners compared with conventional hospital care. J Hum Hypert 1990; 4: 665670.
  • 12
    Hill J, Bird HA. Harmer R, Wright V, et al. An evaluation of effectiveness, safety and acceptability of a nurse practitioner in a rheumatology outpatient clinic. Brit J Rheumatol 1994; 3: 283288.
  • 13
    Campbell NC, Ritchie LD, Thain J, et al. Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care. Heart 1998; 80: 447452.
  • 14
    Rubin PC, Curzio JL, Kelman A, et al. Preliminary experience with a hospital blood pressure follow up clinic with nurse practitioner assessment and microprocessor based data retrieval. BMJ 1984; 289: 537539.
  • 15
    Sandford A, Davies R. A multi-disciplinary approach to hypertension management. Diabet Med 2000; 17(Suppl 1): A6.
  • 16
    United Kingdom nursing and Midwidery Council: Standard for specialist education and practice, 2001. Available at http://www.nmc-uk.org/aFrameDisplay.aspx?DocumentID=661 [Accessed 9 July 2007].
  • 17
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499502.
  • 18
    New JP, Mason JM, Freemantle N, et al. Specialist nurse-led intervention to treat and control hypertension and hyperlipidaemia in diabetes (SPLINT): a randomized controlled trial. Diabetes Care 2003; 26: 22502255.
  • 19
    Woodward A, Wallymahmed, J Wilding, et al. Successful cardiovascular risk reduction in type 2 diabetes by nurse-led care using an open clinical algorithm. Diabet Med 2006; 23: 780787.
  • 20
    Gaede P, Vedel P, Larsen N, et al. Multifactorial Intervention and cardiovascular disease in patients with type 2 diabetes. N Eng J Med 2003; 348: 383393.
  • 21
    Denver EA, Barnard M, Woolfson RG, et al. Management of uncontrolled hypertension in a nurse-led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care 2003; 26: 22562260.
  • 22
    Gaede P, Vedel P, Parving HH, et al. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 diabetes randomized study. Lancet 1999; 353: 617722.
  • 23
    Daly LE, Mulcahy R, Graham IM, et al. Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. BMJ 1983; 287: 324326.
  • 24
    Clarke P, Gray A, Legood R,et al. The impact of diabetes-related complications on health costs: results from the United Kingdom Prospective Diabetes Study (UKPDS No. 65). Diabet Med 2003; 20: 442450.
  • 25
    Colhoun HM, Dong W, Barakat MT, et al. The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: a population-based analysis from the Health Survey for England 1991– 94. Diabet Med 1999; 16: 3540.
  • 26
    British Cardiac Society, British Hypertension Society, Diabetes UK, et al. JBS2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91 (Suppl V): v1v52.
  • 27
    Parving HH, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in people with type 2 diabetes. N Eng J Med 2001; 345: 870878.
  • 28
    Wilmer WA, Hebert LA, Lewis EJ, et al. Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of people in the Captopril study. Am J Kidney Dis 1999; 34: 308314.